Seattle, WA, United States of America

Christopher I Li

This inventor holds 1 USPTO granted patent. Top assignees: Fred Hutchinson Cancer Center, University of Michigan. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher I Li. Retrieved from https://idiyas.com/inventor/christopher-i-li

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christopher I Li: Innovator in Cancer Treatment

Introduction

Christopher I Li is a notable inventor based in Seattle, WA. He has made significant contributions to the field of cancer research, particularly in the treatment of breast cancer. His innovative work has the potential to impact many lives.

Latest Patents

Christopher I Li holds a patent for "Compositions and methods for treating breast cancer." This patent includes compositions and methods for cancer diagnosis, research, and therapy, focusing on cancer markers. Specifically, it provides methods for treating basal-like breast cancer based on the expression levels of a panel of cancer markers. He has 1 patent to his name.

Career Highlights

Throughout his career, Christopher has worked with prestigious institutions such as the University of Michigan and Fred Hutchinson Cancer Center. His experience in these organizations has allowed him to develop and refine his innovative approaches to cancer treatment.

Collaborations

Some of his notable coworkers include Marcin Cieslik and Arul M Chinnaiyan. Their collaboration has likely contributed to the advancement of research in cancer therapies.

Conclusion

Christopher I Li is a dedicated inventor whose work in cancer treatment showcases the importance of innovation in medical research. His contributions are paving the way for new methods to combat breast cancer effectively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…